Auckland, New Zealand

Graham John Atwell

USPTO Granted Patents = 21 

Average Co-Inventor Count = 3.8

ph-index = 6

Forward Citations = 116(Granted Patents)


Location History:

  • Meadowband, Auckland 5, NZ (1989)
  • Meadowbank, NZ (1994 - 1999)
  • Auckland, NZ (1982 - 2010)

Company Filing History:


Years Active: 1982-2010

Loading Chart...
21 patents (USPTO):Explore Patents

Title: Graham John Atwell: Innovator in Cancer Therapy

Introduction

Graham John Atwell is a prominent inventor based in Auckland, New Zealand. With a remarkable portfolio of 20 patents, he has significantly contributed to advancements in medical technologies, particularly in cancer therapy and related fields. His innovative work emphasizes the development of prodrugs and selective treatments for cancer, showcasing his dedication to improving patient care through scientific discoveries.

Latest Patents

Among his notable inventions, Graham has recently developed two important patents. The first patent involves "Nitroaniline-based alkylating agents and their use as prodrugs". This invention focuses on a specialized method for preparing nitroaniline-based unsymmetrical mustards, with applications in gene-dependent enzyme prodrug therapy (GDEPT) and cell ablation therapy. These compounds act as hypoxia-selective cytotoxins and have potential as anticancer agents.

The second of his latest patents pertains to "Nitrobenzindoles and their use in cancer therapy". This innovation encompasses nitro-1,2-dihydro-3H-benzo[e]indoles and their analogues, which serve as hypoxia-selective drugs and radiosensitizers in cancer treatment. These compounds can be utilized alone or in combination with radiation and/or other anticancer medications, thus enhancing therapeutic outcomes.

Career Highlights

Graham Atwell has had a distinguished career marked by significant contributions to medical research and innovation. He has been associated with Auckland Uniservices Limited, where he has applied his expertise to drive advancements in technology and healthcare solutions. Additionally, his involvement with the Development Finance Corporation of New Zealand highlights his commitment to fostering innovation in the region.

Collaborations

Throughout his career, Graham has collaborated with esteemed professionals such as William Alexander Denny and Bruce Charles Baguley. These partnerships have facilitated the development of groundbreaking therapies and have strengthened the research community's ability to tackle challenging health issues.

Conclusion

Graham John Atwell's innovative contributions to cancer therapy exemplify his dedication to advancing medical science. His patents, focusing on targeted drug therapies, reflect a commitment to improving treatment modalities for cancer patients. As his work continues to progress, Graham's influence in the field of medical innovations is expected to have a profound impact on healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…